1Scagliotti G.Optimizing chemotherapy for patients with advanced nonsmall cell lung cancer[J].J Thorac Oncol,2007,2 Suppl 2:S86 -91.
2Devlin JG,Langer CJ.Salvage therapy with vinorelbine in advanced non-small-cell lung cancer:a retrospective review of the Fox Chase Cancer Center experience and a review of the literature[J].Clin Lung Cancer,2007,8(5):319-326.
3Sekine I,Nokihara H,Sumi M,et al.Docetaxel consolidation therapy following cisplatin,vinorelbine,and concurrent thoracic radiotherapy in patients with unresectable stage Ⅲ non-small cell lung cancer[J].J Thorac Oncol,2006,1(8):810-815.
4Hirsh V,Desjardins P,Needles BM,et al.Oral versus intravenous administration of vinorelbine as a single agent for the first-line treatment of metastatic non-small-cell lung carcinoma (NSCLC):A randomized phase Ⅱ trial[J].Am J Clin Oncol,2007,30(3):245 -251.
5Hosomi Y,Shibuya M.Non-cisplatin based chemotherapy in advanced non-small-cell lung cancer[J].Gan To Kagaku Rycho,2007,34(4):527-532.
6Hirsh V Desjardins P, Needles BM,et al.Oral versus intravenousadministration of vinorelbine as a single agent for the first line treatment of metastatic non-small cell lung carcinoma (NSCLC):A randomized phaseil trial [J]. Am J Olin Onco,I 2007,50(3).245-251.
7Hosomi Y,Shibuya M.Non-cispiatin based chemotherapy in advanced non-small ceil lung cancer[J].Gan To Kagaku Eyoho,2007,34(4):527-532.
8Gridelli C. The MILES (multicenter Italian lung cancer in the elderly study) phase 3 trial: gemcitabine + vinorelbine vs vinorelbine and vs gemcitabine in elderly advanced NSCLC patients[J].Proc ASCO, 2001, 20:308a.
9GRIDELLI C,AAPRO M,ARDIZZONI A,et al.Treatment of advanced non-small-cell lung cancer in the elderly:results of an inteanational expert panel[J].J Clin Oncol,2005,23:3125-3137.
10BREATHNACH O S,FREIDLIN B,CONLEY B,et al.Twenty-two years of phase Ⅲ trials for patients with advanced non-small-cell lung cancer:sobering results[J].J Clin Oncol,2001,19:1734-1742.
